[go: up one dir, main page]

WO2009044010A3 - Utilisation d'au moins un dérivé oxime de la cholest-4-èn-3-one comme antioxydants - Google Patents

Utilisation d'au moins un dérivé oxime de la cholest-4-èn-3-one comme antioxydants Download PDF

Info

Publication number
WO2009044010A3
WO2009044010A3 PCT/FR2008/001101 FR2008001101W WO2009044010A3 WO 2009044010 A3 WO2009044010 A3 WO 2009044010A3 FR 2008001101 W FR2008001101 W FR 2008001101W WO 2009044010 A3 WO2009044010 A3 WO 2009044010A3
Authority
WO
WIPO (PCT)
Prior art keywords
cholest
antioxidants
oxime derivative
food
oxime
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2008/001101
Other languages
English (en)
Other versions
WO2009044010A2 (fr
Inventor
Rebecca Pruss
Cyrille Drouot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trophos SA
Original Assignee
Trophos SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA2697125A priority Critical patent/CA2697125A1/fr
Priority to MX2010000915A priority patent/MX2010000915A/es
Priority to JP2010517450A priority patent/JP2010534227A/ja
Priority to BRPI0814580-6A2A priority patent/BRPI0814580A2/pt
Priority to RU2010106614/13A priority patent/RU2475052C2/ru
Priority to NZ582646A priority patent/NZ582646A/xx
Priority to EP08836563A priority patent/EP2173198A2/fr
Priority to AU2008306838A priority patent/AU2008306838A1/en
Application filed by Trophos SA filed Critical Trophos SA
Priority to US12/670,459 priority patent/US20100267680A1/en
Publication of WO2009044010A2 publication Critical patent/WO2009044010A2/fr
Publication of WO2009044010A3 publication Critical patent/WO2009044010A3/fr
Priority to ZA2010/00192A priority patent/ZA201000192B/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/742—Organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/762—Organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B70/00—Preservation of non-alcoholic beverages
    • A23B70/10—Preservation of non-alcoholic beverages by addition of preservatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

L'invention concerne l'utilisation d'au moins un dérivé oxime de la cholest-4- èn-3-one comme antioxydants dans les domaines cosmétiques et alimentaires, et comme conservateurs antioxydant utilisables notamment dans des produits cosmétiques, alimentaires, et pharmaceutiques.
PCT/FR2008/001101 2007-07-25 2008-07-24 Utilisation d'au moins un dérivé oxime de la cholest-4-èn-3-one comme antioxydants Ceased WO2009044010A2 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
EP08836563A EP2173198A2 (fr) 2007-07-25 2008-07-24 Utilisation d'au moins un dérivé oxime de la cholest-4-èn-3-one comme antioxydants
JP2010517450A JP2010534227A (ja) 2007-07-25 2008-07-24 少なくとも１つのコレスト−４−エン−３−オンオキシム誘導体の酸化防止剤としての使用
BRPI0814580-6A2A BRPI0814580A2 (pt) 2007-07-25 2008-07-24 Utilização de pelo menos um derivado de oxima da colest-4-en-3-ona ou um dos seus sais de adição com ácidos aceitáveis, ou de um dos seus ésteres ou de um dos sais de adição dos referidos ésteres com os ácidos aceitáveis
RU2010106614/13A RU2475052C2 (ru) 2007-07-25 2008-07-24 Применение по меньшей мере одного производного оксима холест-4-ен-3-она в качестве антиоксиданта
NZ582646A NZ582646A (en) 2007-07-25 2008-07-24 Use of at least one oxime derivative of cholest-4-en-3-one as antioxidants
CA2697125A CA2697125A1 (fr) 2007-07-25 2008-07-24 Utilisation d'au moins un derive oxime de la cholest-4-en-3-one comme antioxydants
MX2010000915A MX2010000915A (es) 2007-07-25 2008-07-24 Uso de cuando menos un derivado de oxima de colest-4-en-3-ona como antioxidantes.
AU2008306838A AU2008306838A1 (en) 2007-07-25 2008-07-24 Use of at least one oxime derivative of cholest-4-en-3-one as antioxidants
US12/670,459 US20100267680A1 (en) 2007-07-25 2008-07-24 Use of at least one oxime derivative of cholest-4-en-3-one as antioxidants
ZA2010/00192A ZA201000192B (en) 2007-07-25 2010-01-11 Use of at least one oxime derivative of cholest-4-en-3-one as antioxidants

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0705426 2007-07-25
FR0705426A FR2919180B1 (fr) 2007-07-25 2007-07-25 Utilisation d'au moins un derive oxime de la cholest-4-en-3-one comme antioxydants

Publications (2)

Publication Number Publication Date
WO2009044010A2 WO2009044010A2 (fr) 2009-04-09
WO2009044010A3 true WO2009044010A3 (fr) 2009-11-05

Family

ID=39167758

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/001101 Ceased WO2009044010A2 (fr) 2007-07-25 2008-07-24 Utilisation d'au moins un dérivé oxime de la cholest-4-èn-3-one comme antioxydants

Country Status (12)

Country Link
US (1) US20100267680A1 (fr)
EP (1) EP2173198A2 (fr)
JP (1) JP2010534227A (fr)
AU (1) AU2008306838A1 (fr)
BR (1) BRPI0814580A2 (fr)
CA (1) CA2697125A1 (fr)
FR (1) FR2919180B1 (fr)
MX (1) MX2010000915A (fr)
NZ (1) NZ582646A (fr)
RU (1) RU2475052C2 (fr)
WO (1) WO2009044010A2 (fr)
ZA (1) ZA201000192B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2874923B1 (fr) * 2004-09-07 2006-10-27 Trophos Sa Application a titre de medicaments de derives du 3, 5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation
FR2919182B1 (fr) * 2007-07-25 2009-11-13 Trophos Utilisation d'au moins un derive oxime du 3,5-seco-4-nor-cholestane comme antioxydants
FR2979239A1 (fr) 2011-08-25 2013-03-01 Trophos Liposome comprenant au moins un derive de cholesterol
CN109952286B (zh) * 2016-11-15 2022-03-22 香港浸会大学 基于石斛属成分的皮肤保护组合物
CN108113996A (zh) * 2016-11-29 2018-06-05 中国人民解放军军事医学科学院毒物药物研究所 一种用于化学毒剂防护的水溶性皮肤防护剂及其制备方法和用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61148111A (ja) * 1984-12-21 1986-07-05 Ichimaru Fuarukosu Kk 発毛促進剤
US20060217358A1 (en) * 2003-03-11 2006-09-28 Trophos Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU487923A1 (ru) * 1973-07-04 1975-10-15 Ордена Трудового Красного Знамени Институт Кристаллографии Им.А.В.Шубникова Стабильна жидкокристаллическа смесь
FR2581542B1 (fr) 1985-05-07 1988-02-19 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
DE19834812A1 (de) * 1998-08-01 2000-02-03 Beiersdorf Ag Verwendung von Sterolderivaten in kosmetischen und dermatologischen Zubereitungen zur Stärkung der Barrierefunktion der Haut
FR2874923B1 (fr) * 2004-09-07 2006-10-27 Trophos Sa Application a titre de medicaments de derives du 3, 5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation
US20060198809A1 (en) * 2005-03-04 2006-09-07 Woodridge Labs, Inc. Gamma-amino butyric acid composition
FR2894968B1 (fr) 2005-12-20 2008-02-22 Trophos Sa Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation
FR2898272B1 (fr) * 2006-03-09 2008-07-04 Trophos Sa Utilisation de derives du 3,5-seco-4-nor-cholestrane pour l'obtention d'un medicament cytoprotecteur
FR2899108B1 (fr) * 2006-03-31 2012-02-03 Trophos Utilisation de derives du cholest-4-en-3-one pour l'obtention d'un medicament cytoprotecteur
FR2914188B1 (fr) * 2007-03-28 2012-06-22 Trophos Nouvelle composition a base d'oxime de cholest-4-en-3-one
FR2919182B1 (fr) * 2007-07-25 2009-11-13 Trophos Utilisation d'au moins un derive oxime du 3,5-seco-4-nor-cholestane comme antioxydants
RU2485956C2 (ru) * 2007-10-30 2013-06-27 Трофо Новая композиция для лечения побочных эффектов противораковой терапии
FR2934596B1 (fr) * 2008-07-30 2015-04-10 Trophos Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation
FR2940650B1 (fr) * 2008-12-29 2017-01-27 Trophos Nouveaux derives d'oxime du 3,5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant,et procede de preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61148111A (ja) * 1984-12-21 1986-07-05 Ichimaru Fuarukosu Kk 発毛促進剤
US20060217358A1 (en) * 2003-03-11 2006-09-28 Trophos Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 198633, Derwent World Patents Index; AN 1986-216089, XP002544222 *
KOBAYASHI M ET AL: "POLYPHOSPHORIC ACID-CATALYZED BECKMANN REARRANGEMENT OF 3-KETO-STEROID OXIMES", 1969, CHEMICAL AND PHARMACEUTICAL BULLETIN, TOKYO, JP, PAGE(S) 1255-1260, ISSN: 0009-2363, XP008029833 *
KOLAK U ET AL: "CARDIOACTIVE DITERPENOIDS FROM THE ROOTS OF SALVIA AMPLEXICAULIS", 2001, PLANTA MEDICA, THIEME, STUTTGART, DE, PAGE(S) 761-763, ISSN: 0032-0943, XP008033781 *
SUZUKI K ET AL: "The cholesterol metabolite cholest-4-en-3-one and its 3-oxo derivatives suppress body weight gain, body fat accumulation and serum lipid concentration in mice", 18 August 1998, BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, PAGE(S) 2133-2138, ISSN: 0960-894X, XP004137233 *

Also Published As

Publication number Publication date
NZ582646A (en) 2012-11-30
RU2010106614A (ru) 2011-08-27
ZA201000192B (en) 2011-05-25
AU2008306838A1 (en) 2009-04-09
US20100267680A1 (en) 2010-10-21
BRPI0814580A2 (pt) 2014-10-07
WO2009044010A2 (fr) 2009-04-09
CA2697125A1 (fr) 2009-04-09
RU2475052C2 (ru) 2013-02-20
FR2919180B1 (fr) 2009-11-27
EP2173198A2 (fr) 2010-04-14
FR2919180A1 (fr) 2009-01-30
MX2010000915A (es) 2010-03-01
JP2010534227A (ja) 2010-11-04

Similar Documents

Publication Publication Date Title
EP2224973A4 (fr) Conservateurs pour compositions cosmétiques, de toilette et pharmaceutiques
EP3270707A4 (fr) Phytocomplexes présentant de multiples activités antioxydantes synergiques, utiles dans des aliments, des compléments alimentaires, des produits cosmétiques et des préparations pharmaceutiques
WO2009155397A3 (fr) Produits holographiques comestibles en soie
WO2011073437A3 (fr) Compositions cosmétiques ou dermatologiques à base de bactériocines et de prébiotiques
PL2173195T3 (pl) Biomasa wzbogacona w cynk, sposób jej wytwarzania oraz zawierające ją produkty probiotyczne, kosmetyczne, dietetyczne i nutraceutyczne
IL210673A (en) Fats, supplements and preparations containing them and their uses
WO2009050580A8 (fr) Composition destinee a la regulation du metabolism des lipides
WO2012002669A3 (fr) Composition cosmétique pour prévenir le vieillissement cutané
WO2011059292A3 (fr) Concentré ou extrait de pousse d'aloès officinal favorisant fortement la croissance des cellules cutanées et présentant des effets anti-allergiques et antioxydants supérieurs
WO2011052950A3 (fr) Composition pharmaceutique contenant un composé indole
WO2011106423A3 (fr) Formulations à base d'acai et d'iridoïdes
EP3677243A4 (fr) Composition cosmétique comprenant un antioxydant physiologiquement actif et produit cosmétique à double couche comprenant celle-ci
WO2008145247A3 (fr) Agent antioxydant pour aliments
WO2013117599A3 (fr) Confiseries glacées à faible teneur en protéines
WO2012091440A3 (fr) Composition pour l'amélioration, le traitement et la prévention de troubles de la motilité du tractus gastro-intestinal
WO2010046061A3 (fr) Préparations cosmétiques et/ou pharmaceutiques
WO2014167247A3 (fr) Composition cosmetique, pharmaceutique ou alimentaire comprenant un extrait riche en carotenoides d'arthrobacter agilis
IL212567A (en) Zaxanthin, alone or in combination with rutin, spermidine, or both, for the treatment of scalp disorders, use of zaxanthin, alone or in combination with rutin, spermidine or both, for the preparation of a medicinal or cosmetic or nutritional preparation for the treatment of scalp, and a medicinal, cosmetic or nutritional preparation containing Alone or in a mixture with routine, spermidine, or both
WO2011043631A3 (fr) Composition pharmaceutique pour la prévention et le traitement du rhume, contenant un extrait de reynoutria elliptica, une fraction de celui-ci ou un composé à base de stilbène
WO2009044010A3 (fr) Utilisation d'au moins un dérivé oxime de la cholest-4-èn-3-one comme antioxydants
WO2009138801A3 (fr) Formulation cosmétique
WO2010149323A3 (fr) Compositions de beurre de cacao mou
WO2014144891A3 (fr) Composition de conservateur naturel à spectre large
MX2014014517A (es) Composiciones topicas bajo la forma de un gel que contiene un retinoide particular solubilizado.
WO2007137297A3 (fr) Aliments et boissons contenant des additifs

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08836563

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008306838

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 582646

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2697125

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2010517450

Country of ref document: JP

Ref document number: 451/CHENP/2010

Country of ref document: IN

Ref document number: MX/A/2010/000915

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008836563

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2008306838

Country of ref document: AU

Date of ref document: 20080724

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2010106614

Country of ref document: RU

WWE Wipo information: entry into national phase

Ref document number: 12670459

Country of ref document: US

ENP Entry into the national phase

Ref document number: PI0814580

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20100122